Return to flip book view

Message nutriventia.com | sales@nutriventia.comScience backed, tech driven,clean ingredients that‘ ’

Nutriventia E.D.G.E.Enhanced Delivery for Greater EicacyAt the heart of every product is Our proprietary delivery technology platformsOur breakthrough products built for youModifiedRelease5Complete musculoskeletalhealth in a single 250mgdaily doseComplete beauty and radiance with a single 250mg daily doseAll day immune support with a singleprecise dose12-hour mental focus and alertness, powered by a singlemilli dose8 hour natural sleep cycle, from micro to millidoses5All-day stress support starting at a single150mg daily dose

TurmXTRA™ is a patented, water-dispersible, clinically validated turmeric extract supporting joint comfort, mobility, post-exercise muscle recovery, and overall musculoskeletal wellness. Standardized to 60% curcuminoids, it delivers superior systemic exposure at 10X lower doses than conventional turmeric extracts for efficient absorption and rapid action. Clinical studies show TurmXTRA™ enhances joint function, mobility, and recovery while supporting post excercise healthy inflammatory responses. Safe and well tolerated, it is ideal for nutritional formulations targeting active lifestyles and daily musculoskeletal support.Peak musculoskeletal healthHigher consumer complianceA low one-a-day dose provides higher consumer compliance.All-naturalNo use of synthetic excipients and surfactants.activeLearn more >Water dispersible turmeric extract with clinically proven absorption efficiency at a low dose of 250 mg*Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.353PKSTUDIES3CLINICAL STUDIESJOINT, DOMS, OA1META-ANALYSIS ANDSYSTEMATIC REVIEWThe global joint health supplements market is significantly growing, driven by an aging population and increased physical activity. Turmeric is one of the fastest growing active in the segment, favored for its natural anti-inflammatory benefits. Consumers today increasingly seek natural, low dose, and effective solutions available in convenient consumption formats for ease and compliance.APPLICATIONSGummiesHardCapsulesEffervescent TabletsStick PacksReady-To-DrinkMARKET INSIGHTSMarket Value$7 billion7-8%CAGR (by 2030) Joint healthSource: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Grandview Reserch Report 2025.

*A complete clinical package3 PHARMACOKINETIC STUDYSTUDY 1 AND STUDY 2One 250 mg dose of TurmXTRA™ is clinically substantiated to show equivalenceto three 500 mg doses of standard 95% turmeric extract. Two independent human PK studies demonstrated consistent results, confirming the reliability of curcuminoid absorption from TurmXTRA™.Pharmacokinetic study 1Source: Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative bioavailability of curcuminoidsfrom a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over,comparative, pharmacokinetic study. J Pharm Pharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028.PMID: 33755149.Time (h)Mean plasma concentration of totalcurcuminoids (ng/mL)004 8 121020 24203040506070809016TurmXTRA™ Std 95%TETurmXTRA™ Time (h)Mean plasma concentration of totalcurcuminoids (ng/mL)004 8 121020 24203040506016Std 95%TEPharmacokinetic study 2STUDY 3One 250 mg dose of TurmXTRA™ is clinically substantiated to show comparable kinetics to three 500 mg doses of a well known branded ingredient containing turmeric and piperine taken at three different time intervals. Source: Thanawala S, Shah R, Doyle L, Upadhyay V. Comparative pharmacokinetics of curcuminoids from waterdispersible turmeric extract against a curcuminoids-piperine combination : An open label, randomized, balanced,2-Treatment, 2-Sequence, 2-Period Crossover Study. Alt Ther. 2024 Apr; 30 (4) : 18-23Pharmacokinetic study 3Mean plasma concentration of totalcurcuminoids (ng/mL)004 6 81020 2420304050607016TurmXTRA™ Branded 95% TE+5mg piperineTime (h)Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.

TurmXTRA™ PlaceboSource: Thanawala S, Shah R, Karlapudi V, Desomayanandam P, Bhuvanendran A. Efficacy and Safety of TurmXTRA® in Delayed Onset MuscleSoreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement AlternatMed. 2022 Aug 5;2022:9110414. doi: 10.1155/2022/9110414. PMID: 35966736; PMCID: PMC9374544.STUDY 5 - DELAYED ONSET MUSCLE SORENESS DOMS STUDYOur randomized, double-blind, placebo-controlled trial on 30 healthy and recreationally active subjects showed the efficacy of TurmXTRA™ in reducing muscle soreness and increasing overall well-being.Change in Recovery Timecompared to placeboChange in Muscle Soreness Recovery as compared to placeboHigher levels of recovery96 hrs post workout1.5x improvementTime (hr)Percentage RecoveryFaster recoveryIn H&M Fatigue Scale4x fasterChange in LDH levelscompared to placeboBetter Recovery72 hrs post workout~9x improvementLDH levelsChange in time in80 meter fast paced walkMore agility~2x improvementJoint comfortimprovement19%Mobilityimprovement2xOur randomized, double-blind placebo-controlled study on 96 healthy volunteers showed the efficacy of TurmXTRA™ on joint health with significant results.Time (s)Change in pain (VAS) after80 meter fast paced walkMore comfort~3x improvementVASChange in time in9 stair climbMore agility~1.5x improvementTime (s)TurmXTRA™ PlaceboSource: Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative bioavailability of curcuminoids from a water-dispersiblehigh curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study. J PharmPharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028. PMID: 33755149.Journal of Pharmacy and Pharmacology, Oxford University PressSTUDY 4 - JOINT HEALTH STUDYAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.

2.4x improvementVisual analog scale (100 mm)HEALTH BENEFITSJointhealthHealthyagingBrainhealthImmunehealthLiverhealthLICENSES & CERTIFICATIONSScan to visit websitefor more informationRandomized, double-blind, placebo controlled, parallel group 90 day study on 139 subjects with mild to moderate knee osteoarthritis proved the efficacy and safety of TurmXTRA™ in significantly reducing pain and improving comfort & knee function.STUDY 6 - OSTEOARTHRITIS STUDYReduced Pain (KOOS) Better Knee FunctionNearly 4x improvement 2.3x improvementTurmXTRA™ PlaceboChange in pain (VAS) ascompared to placeboBetter Comfort (VAS)Knee Injury and Osteoarthritis Outcome scoreChange in pain (KOOS)as compared to placeboChange in knee related quality oflife as compared to placeboKOOS – Pain scoreVAS – Pain scoreEase in knee mobilityTurmXTRA™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your regionThanawala S, Shah R, Alluri K V, Bhupathiraju K, Prasad N, Agarwal N.Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Pain Res 2025 Jan 25 ; 18 : 411 – 427.

3CLINICAL STUDIESJOINT, DOMS, OATurmXTRATM is a standardized turmeric extract providing 150 mg of curcuminoids in a precise 250 mg serving with a potent concentration. Its innovative formulation enhances absorption and effectiveness at a lower dosage compared to traditional turmeric extracts. Produced without any artificial additives or synthetic carriers, TurmXTRATM meets consumer demand for authenticity and simplicity. Designed for versatility and purity, this extract supports long-term supplementation with a safety profile that underscores its quality and reliability. TurmXTRATM represents the forefront of turmeric innovation for modern wellness formulations.The global skin health and beauty-from-within market is poised to grow rapidly over the next few years. Consumer interest remains strong, with 28% of individuals expressing preference for supplements targeting skin, hair, and nail health. From a supplementation perspective, efficacy emerges as the leading purchasing driver, underscoring the importance for manufacturers to deliver scientifically backed, results-oriented products. This growing demand signals significant opportunities for brands to cater to consumers seeking effective, ingestible solutions for skin wellness from within.Elevate your glow from withinCurcuminoid content (60% Total Curcuminoids)Clinically substantiated at a lower dose of 250 mgAll-naturalClinically Proven Turmeric Extract for Skin Health MARKET INSIGHTSBeauty from withinMarket Value$1.5 billion2.3%CAGR (by 2026) Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Source: NBJ Condition Specific Report 2023, 2024 CRN Consumer SurveyLearn more >New LaunchHigher convenience for formulator & consumerWater dispersible turmeric extract3PK STUDIES*1CLINICAL STUDY*Refer to TurmXTRATM activeglow

SKIN HEALTHSELF-ASSESSMENT QUESTIONNAIRE FOR EFFICACYTurmXTRA™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your regionLICENSES & CERTIFICATIONSAPPLICATIONSGummiesHardcapsulesEffervescent TabletsStick PacksReady-To-DrinkSource: J Cosmet Dermatol. 2025; Efficacy and safety of low-dose turmeric extract on facial skin. doi:10.1111/jocd.70462Randomized, double blind, placebo controlled, 60 day clinical study was conducted in 96 healthy female subjects presenting with facial blemishes, received a daily supplementation of 250 mg TurmXTRATM Glow.Once-daily TurmXTRATM Glow supplementation for 60 days visibly improved overall skin quality versus placebo, including skin clarity, tone evenness, hydration, and natural radiance. Improvements in skin smoothness and moisture retention were observed, supporting healthier-looking, more luminous skin.Scan to visit websitefor more information-3-2.5-2-1.5-1-0.500.51Change in moisture retention from baseline to Day 604X reduction-4-202468Change in hydration levels from baseline to Day 603.4X improvement00.20.40.60.811.21.41.6Change from baseline to Day 604.2X improvement00.20.40.60.811.21.47.4X improvement00.20.40.60.811.21.41.61.8Change from baseline to Day 602.7X improvement-1.8-1.6-1.4-1.2-1-0.8-0.6-0.4-0.20Change in pigmentation intensity from baseline to Day 607X reduction Change from baseline to Day 60Perceived Skin Softness andSmoothness Perceived Skin MoisturizationPerceivedSkin Glow Premarked Blemishes viaAntera imaging Transepidermal water loss via VapoMeter Skin hydration via Moisture MeterTurmXTRA™ PlaceboTurmXTRA™ Placebo

USP compliantMultiple randomized, double-blind, placebo-controlledclinical trials for validating stress managementValidated with a full clinical package forprolonged release.TMAlso known as *Learn more >Root-only, SustainedRelease AshwagandhaAll-day calmAshwagandha is recognized as the fastest growing active ingredient in the stress and adaptogen supplement segment, driven by rising consumer interest in natural stress relief and support. This growth is supported by a heightened awareness of mental health and proactive approaches to emotional well-being worldwide. MARKET INSIGHTSEervescent TabletsGummiesOrodispersiblePowderCapsulesAPPLICATIONSStress & AdaptogenMarket Value$0.6 billion5.1%CAGR (by 2034) Source: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Grandview Reserch Report 2025.*Trademarked as AshwanovaTM in some parts of the worldTMAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.5ProlanzaTM is a unique long acting ashwagandha root extract standardized to contain 10 USP compliant withanolides. It’s innovative release pattern ensures extended clinical benefits.1PK STUDY3CLINICAL STUDIES

STUDY 1 – PHARMACOKINETIC STUDYCompared to a leading branded Ashwagandha ingredient, ProlanzaTM showed -:Superior pharmacokinetic profileProlanzaTM has a bioavailability which is nearly12 times higher as compared to the reference product.Extended AvailabilityWithanolides from ProlanzaTM are available in plasma for upto24 hours A comprehensive clinical package0 2 4 6 8 10 12 14 16 18 20 22 2400.511.522.53ReferenceTime (hrs.)Mean plasma concentration of totalwithanolidies (ng/mL)STUDY 2 – A STRESS & COGNITIVE HEALTH STUDYA randomized, double blind, placebo controlled 90 day clinical study in 100 healthy adults aged 20–55 with mild to moderate stress evaluated daily supplementation with 300 mg of ProlanzaTM. Once daily ProlanzaTM significantly improved cognitive performance versus placebo, including recall memory, visual accuracy, and target detection. Significant reductions in stress and cortisol levels were observed, along with improvements in sleep quality and mental well-being.Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Stress biomarker Serum cortisol levelsStressPerceived Stress ScaleSleep qualityPerceived Sleep Quality Index Memory recall Cambridge Neuropsychological Test Automated Battery (CANTAB)Emotional and Mental Well-beingOverall Happiness Quotient - 8 Visual accuracy Cambridge NeuropsychologicalTest Automated Battery (CANTAB)-8-6-4-2024Chnage from baseline to Day 90-3-2-1012Change from baseline to Day 9000.511.522.533.5X Improvement 9.3X Reduction-0.8-0.30.20.72X Improvement PlaceboProlanza™ Shefali Thanawala*, Rajat Shah, Kiran Bhupathiraju, Krishnaraju Venkata Alluri, Prabakaran Desomayanandanam, Arun BhuvenendranPosted Date: 19 February 2025doi: 10.20944/preprints202502.1076.v2Keywords: ashwagandha; happiness; sleep; stress; sustained- release; withanolides-10123Change from baseline to Day 90 -9-416Change from baseline to Day 903.6X Improvement 1.5X Improvement 1.7X Reduction

-10-8-6-4-2024Change from baseline to Day 600123456Change from baseline to Day 60STUDY 3 – 150 MG PROLANZA VS 300 MG PROLANZA VS PLACEBO – STRESS STUDYA randomized, double-blind, placebo-controlled 60 day clinical study in 126 healthy adults aged 20–55 with mild to moderate stress evaluated once daily supplementation with 150 mg or 300 mg of ProlanzaTM versus placebo. Both doses produced rapid, dose dependent reductions in stress compared with placebo, along with improvements in sleep quality, mood, and eating behavior.Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Sleep Quality Perceived Sleep Quality IndexStressPerceived Stress Scale2.7XReduction3.9XImprovement 4.8XImprovement 3.1XReductionEmotional Eating Third Factor Eating Questionnaire (TFEQ)Emotional and Mental Well-beingOverall Happiness Quotient - 8 (OHQ-8)Placebo300 mg Prolanza™ 150 mg Prolanza™ 00.20.40.60.811.21.4Change from a bseline to Day 60-2-1.5-1-0.500.5111.8X Improvement 13X Improvement 0.6X Improvement 1.1X Improvement Thanawala, S.; Shah, R.; Bhupathiraju, K.; Venkata Alluri, K.; Desomayanandanam, P.; Bhuvenendran, A. Eicacy and Safety of Ashwagandha Root Extract Sustained-Release Capsules in Healthy Adult, Stressed Subjects: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Three-Arm Clinical Trial. Preprints 2025, 2025021076. https://doi.org/10.20944/preprints202502.1076.v1

STUDY 4 – SPORTS STUDYRandomized, double-blind, placebo-controlled clinical study evaluating the safety and muscle strength benefits of 300 mg Prolanza in healthy, recreationally active adults after 90 days of supplementation.When combined with structured training, Prolanza supplementation delivered superior gains in strength and endurance, supported healthy hormonal balance for both men and women, accelerated recovery and resilience to training stress, elevated physical and mental well-being, and emerged as a science-backed ingredient for next-generation sports and active nutrition.RESULTS Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Cardiorespiratory Endurance VO2maxMuscle Strength 1-repetition maximumFree Testosterone Levels(Males) HEALTH BENEFITSStress SupportSleepHealthMental WellbeingCognitive SupportProlanza™ & ashwanova™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comPlease reach out to our Sales Team for information on product availability in your regionLICENSES & CERTIFICATIONSPlaceboProlanza™ 05101520Change from baseline to Day 900510152025303540Change from baseline to Day 902.1XImprovement 1.7XImprovement Manuscript under preparation00.511.522.533.5Change from baseline to Day 901.3X Improvement

All-night sleepMARKET INSIGHTSSleep health ranks among the top reasons for supplement usage. Melatonin dominates this category, holding 57.6% of the sleep supplement market. The melatonin market size is valued at USD 1.89 billion in 2025 and projected to reach USD 3 billion by 2030, growing at a CAGR of 9.67%. Synthetic melatonin represented 55.67% share in 2024 of the total melatonin market, while natural melatonin is gaining traction with clean-label positioning. Learn more >Global Sleep healthMarket Value$7.6 billion5.2%CAGR (by 2034) Source: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Future Market Insights Sleep Supplement Report 2024., Mordor Intelligence Melatonin Market 2025, Arnao et al., 2018 J. Functional Foods.natural 1PK STUDY1CLINICAL STUDYMelotime™ is an sustained release melatonin that helps mimics the body’s natural sleep pattern and supports good quality sleep. The unique release profile of Melotime™ ensures release of a significant portion in the first hour followed by continued release of melatonin upto 6 hours for maintenance. This ensures a quick on-set and maintains good quality of sleep.Sustained Release melatonin that supports a natural 8 hour sleep cycleAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,treat, cure or prevent any disease.8 hour sleep supportSustained release profile helps to get 8 hours of sleep without side effectsSupports natural sleep patternThe unique release profile provides a quick onset and good quality restorative sleep.Sustained release patternReleases up to 50% of melatonin in the first hour with subsequent release in smaller burst for next 6 hours and tappering effect in the final hour to wake fresh.APPLICATIONSTabletsCapsulesGummies & chewsStick packs(powder)*Melotime also available as sourced from St. John’s wort.

SLEEP STUDYPOLYSOMNOGRAPHYPHARMACOKINETIC STUDY16 healthy adult subjects were randomized to receive a single oral dose of either MelotimeTM Capsules (Melatonin SR Granules 11 mg, equivalent to 5 mg melatonin) or the reference product (R), Melatonin Capsules 5 mg (immediate-release).Randomized, double-blind, placebo-controlled clinical study was conducted in 62 healthy adults with poor sleep quality, as assessed by a Pittsburgh Sleep Quality Index (PSQI) score >5. Subjects received either melatonin 2 mg (MelotimeTM) or placebo once daily for 28 days to evaluate the effectiveness of MelotimeTM in improving sleep parameters.Polysomnography confirms MelotimeTM delivers faster sleep onset, fewer night awakenings, higher sleep efficiency, and a healthier REM–NREM sleep architecture.• Controlled Melatonin ReleaseLower peak levels indicates a more controlled and gradual release profile, which may help maintain steady melatonin exposure without abrupt peaks.• Extended Night Long Coverage5X longer half life supports prolonged melatonin availability, helping maintain sleep support throughout the night.• Sustained Release ProfileA later Tmax reflects sustained melatonin release, designed to align with the body’s natural sleep rhythm rather than rapid release.Melotime™ Melatonin IRTime (h)0180001600014000120001000080006000400020000Mean plasma concentration ofmelatonin (pg/mL)1 2 3 4 5 6 78Disturbed sleepSound sleepFastereliminationSlowereliminationMean plasma concentration ofmelatonin (pg/mL)-8-6-4-202468281.6X ImprovementSleep eiciency-19-14-9-4161116Dierence in duration (minutes) from baseline to Day 281.1X ImprovementREM Sleep% dierence from baseline to Day Dierence in duration (minutes) from baseline to Day 28-30-20-1001020302.7X ImprovementNREM sleepMelotime™ PlaceboAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Source - Thanawala S, Abiraamasundari R, Shah R. Comparative pharmacokinetics of Sustained-release versus Immediate-release melatonin capsules in Fasting healthy adults : a randomized, open-label, cross-over study. Pharmacokinetics. 16, 1248.

PITTSBURGH SLEEP QUALITY INDEX AND WHO-5 WELL-BEING INDEXPARTICIPANTS’ SLEEP DIARYThe findings from PSQI revealed, MelotimeTM significantly improved overall sleep quality, helping users fall asleep faster, sleep longer, and wake up less during the night.WHO-5 Wellbeing Index reflected improved sleep with MelotimeTM translated into better overall well-being, marked by enhanced mood, vitality, emotional balance, and daily functioning.Sleep diary outcomes show MelotimeTM reduces daytime napping, fatigue, and stress while improving alertness, with early benefits seen within two weeks.Number of participants taking a nap during day timeSubjective rest score-101234567816X ImprovementChange from baseline to Day 28Global PSQI score0246810121416Change from baseline to Day 28Wellbeing index17.2X Improvementparticipants feeling alert from 37% reductionfrom baseline % dierence in the number of 33% Improvementbaselinefrom baseline to Day 28participants taking a nap during Dierence in the number of -25-20-15-10-50daytime from baseline to Day 2877% reduction from baseline4% reductionfrom baseline6040200-20-40-604Dierence in score from baseline to Day 283.5X Improvement-2-13210Number of participants feeling alertMelotime™ PlaceboMelotime™ PlaceboAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Source – Under peer review

HEALTH BENEFITSSleepregulationAntioxidantsupportCognitivehealthNaturally sourced melatonin from St. John’s wort (Hypericum perforatum L.)All-natural melatonin with natural excipients, a cleaner alternative to synthetic and free from chemical by-productsOptimized fine particle size (Approx. ~300 μ) for uniformity, consistent quality and performance0204060801000 1 2 3 4 5 6 7 8% release Time (h)Comparison of Dissolution profileMelotime Melotime NThe natural evolution of our trusted sleep solution active.natural Scan to visit websitefor more informationLICENSES & CERTIFICATIONSMelotime™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your regionIntroduces

Caffeine stimulates the nervous system leading to improved alertness, exemplified motor coordination, and recharged focus. The most significant issue with caffeine is that its effects start to diminish after a couple of hours due to quick absorption of caffeine within the body. High and/or multiple doses leads to caffeine tolerance which could lead to jitteriness, headache, and nervousness collectively known as ‘caffeine crash’. CaffXtend™ is a unique patented product that delivers natural caffeine for 12 hours, from a natural matrix using our proprietary modified-release technology.Long-acting caffeine HEALTH BENEFITSAPPLICATIONSAll-naturalSource of natural caffeine is fromcoffee seeds. This caffeine is embedded in a natural release controlling matrix.One-a-day doseA single dose designed for an enhanced caffeine experience, lasting up to 12 hours, offers all-day alertness and focus.Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.HardCapsulesEffervescent TabletsStick PacksImproved focus andmental alertness CaffXtend™ provides 400% lesserperception of fatigue in comparison toregular natural caffeineLearn more >All-day focusGummies1PK STUDYCaffeine is the leading active ingredient in nootropic supplements, driving mental energy, focus, and alertness. NBJ data shows 79% of active consumers take supplements to boost energy and stamina, with 63% preferring natural caffeine sources in sports nutrition. This highlights caffeine’s dominance in cognitive enhancement. The global nootropic market is growing rapidly, with caffeine-based products playing a key role. Its fast, effective mental stimulation makes it the cornerstone ingredient for focus and mental performance.MARKET INSIGHTSNootropicMarket Value$2.3 billion7.8%CAGR (by 2034) Source - NBJ Report, Global Market Insights Nootropic Supplement Market Report 2024.

SUSTAINED RELEASE PROFILEClinically substantiated to reduce perception of ‘tiredness’ for an extended duration (12 hours) from a single doseThe sustained release of caffeine gives 12 hours of enhanced energy* and focus*The claims of energy are more in terms of the general meaning of the word rather than energy as referred to as ATP productionExtended action through sustainedrelease profile of CaffXtend™1.Extended Tmax – 391.57%(to reach maximum concentration)Extended half-life T½ – 22.32% longerSignificantly lower scoresfor ‘tired’ and ‘jittery’3.Lesser perception of tiredness and jittersLower scores for parametersindicative of ‘caffeine crash’4.No caffeine crash, hence saferExtended efficacy through sustainedrelease profile of CaffXtend™ from a Caff-VAS (Caffeine Research Visual Analog Scales)** significantly higher scores for ‘overall mood’, ‘relaxed’and ‘alert’2.Better mood & more alertnessCaffXtend™ is beneficial with better efficacy, as compared to repeated caffeine dosing5.Substantiated from data of human clinical trialcompared with equal dose of natural caffeinePHARMACOKINETIC STUDY#Source: Shefali Thanawala, Rajat Shah, R. Abiraamasundari, R. Senthurselvi & PrabakaranDesomayanandam (2023): Comparative Bioavailability and Benefits on Mental Functions ofNovel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules:An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study, Journalof Dietary Supplements, DOI: 10.1080/19390211.2022.2160529LICENSES & CERTIFICATIONSScan to visit websitefor more informationSharp declineImmediate spikeProgressiveincreaseGradualdeclineMean concentration (pg/ml)0 2 4 6 8 10 120500100015002000250030003500400045005000Time (hrs.) Caffeine IR CaXtend™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region

C-Fence™ is a direct compressible granularsystem of Vitamin C which is an ideal solutionfor manufacturers targeting convenient and continuous 24-hour antioxidant shield. Powered using our modified release technology, small bursts of Vitamin C are consistently released periodically, providing 24-hour antioxidant support. Unlike other sustained release products that are time-consuming to develop and manufacture, C-Fence™ just needs a single-step operation to compress granules into tablets.24 hour optimised Vitamin C direct compressible granulesLong acting, one-a-day doseA single dose provides 24-hour protection making it convenient for end consumers.Natural flow C-Fence™ crafted using nature-derived excipients and patented proprietary process, offers seamless flow, enhancing manufacturing convenience.Assured consistencyEach batch of C-Fence™ undergoes pre-quality evaluation by testingtablets from a representative sample.Safety with low doseC-Fence™ averts gastric distension by gradually releasing modified Vitamin C bursts.Vitamin C is the dominant ingredient, widely recognized for its immune-boosting benefits. Consumer demand is rising for immune health support, especially among the elderly who are more vulnerable to infections. Overall, preventive health focus and growing awareness are fueling this robust market growth.MARKET INSIGHTSAPPLICATIONSTablets CapletAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,treat, cure, or prevent any disease.All-day immunityLearn more >Immune HealthMarket Value$26.6 billion10.72%CAGR (by 2030) 1PK STUDYSource - NBJ Supplement Business Report 2023, Grandview Reserch Immune Health RepotC-fence™ has shown 12-hour sustainedrelease Vitamin C in-vitro.

PHARMACOKINETIC STUDYClinically substantiated through a randomized double-blind, parallel arm, placebo-controlled clinical trial to evaluate the pharmacokinetic profile of Vitamin C from an extended action tablet from C-Fence™. Clinical trial shows that the 12-hour release profile correspondingly produces a sustained level of Vitamin C in the active state in plasma providing a 24-hour in-vivo coverage.IN VITRO DISSOLUTIONSingle dose provides a consistent release for maximum timePolymer matrixWorks by diffusion mechanism from the matrixRelease in small burstsHEALTH BENEFITSLongevitySkinhealthBrainhealthImmunehealthCardiovascularhealthLICENSES & CERTIFICATIONSExtendedTmaxCmax comparedto baseline 0 hrs85xC24 compared to baseline 0 hrs20xXShah R, Thanawala S, Abiraamasundari R. Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled Trial. J Pharmacol Pharmacother. 2022 Jul 21 ; 13 : https://doi.org/10.1177/097650 0X 2 21111669Scan to visit websitefor more informationTime (hrs.)020040060080010001200Avg. concentration of Vit. C (ng/ml)0 2 4 6 8 10 12 14 16 18 20 22 24Placebo85x20xC-Fence™ is a trademark of Nutriventia Pvt. Ltd. © 2026 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region

In just 5 years, Nutriventia has achieved over 165 milestones,accelerating at an exponential pace and this is only the beginning of our rapid growth and expanding global impact. Peer reviewed publications Recognitions07Countries27Granted Global Patents1216Global Patents Applied36Clinical studies 22

sales@nutriventia.comendless opportunities together.Let’s exploreNULBL030226F